U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
  FAQs Site Map About MedelinePlus Contact Us
español
Reuters Health Information Logo

Study finds 10 genes that raise sudden death risk

Printer-friendly version E-mail this page to a friend

Reuters Health

Sunday, March 22, 2009

By Julie Steenhuysen

CHICAGO (Reuters) - Researchers have found nine new gene variations that can make a person vulnerable to sudden cardiac death and confirmed the role of another, international researchers said on Sunday.

"Almost half were surprising new genes that no one would have guessed as being involved in cardiac biology," said Dan Arking of Johns Hopkins University School of Medicine, whose team was one of many working on the study in the journal Nature Genetics.

Last month, Arking's group reported in the journal Circulation that it had found a single gene that raises the risk of cardiac death. The new study identifies that gene plus nine new ones that modify the timing of heart contractions, a measure known as the QT interval.

People with prolonged QT intervals have a higher risk of cardiac death, which accounts for more than 400,000 deaths each year in the United States, according to the American College of Cardiology.

"Sudden cardiac death is a real problem. You don't get a second chance," Arking said in a telephone interview.

The study of 15,842 people showed that the more of these 10 variants a person has, the greater the chances of having a prolonged QT interval.

A heart attack can raise the risk of having this type of abnormal heart rhythm, but people who inherit this genetic risk are often never identified.

"The problem in some sense is most of these people have no known risk factors. They don't have high cholesterol. They are not obese. In some sense, the genetics may be the only hope for some of these people," Arking said.

The next step is to try to identify how great a role each of these genes play in raising risks. Ultimately, he said, the findings might offer a target for new drugs.

(Editing by Maggie Fox and Vicki Allen)


Reuters Health

© 2009 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies. For additional information on other Reuters media services please visit http://about.reuters.com/media/.

Related News:
More News on this Date

Related MedlinePlus Pages: